
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vertex Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
41%
Total
Publications
2K
Total Open
Publications
829
Total
Citations
126K
Open Access
Percentage
41%
Total
Publications
2K
Total Open
Publications
829
Total
Citations
126K
Breakdown
Publisher Open
15%
Both
17%
Other Platform Open
7%
Closed
61%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 36%
226
Hybrid 24%
154
No Guarantees 40%
253
Other Platform Open
Domain 75%
363
Institution 23%
111
Other Internet 15%
72
Public 4%
18
Preprint 3%
14
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 363 |
DOI | Other Internet | 70 |
Europe PMC | Domain | 23 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 19 |
Figshare | Public | 17 |
DANS - Data Archiving and Networked Services | Institution | 14 |
DASH - Digital Access to Scholarship at Harvard | Institution | 11 |
arXiv | Preprint | 10 |
Imperial College London - Spiral | Institution | 9 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 8 |